stryker hip replacement

Stryker Hip Replacement In July 2012, Stryker Orthopaedics recalled two of its hip replacement products, the Rejuvenate Modular and the ABG II. This recall came just years after the FDA approved the Rejuvenate device in June 2008 device and the ABG II device in November 2009. Both of these products were designed using the dangerous metal-on-metal method. Previously in January 2008, Stryker had recalled its Trident hip system because its "CeramTec" material was not durable. Common Side Effects: Too Many 1% + 3% = Dead Swelling Pain Serious Side Effects: "Squeaky Joints" Osteolysis Ossification Infection Debris buildup The lowa Orthopaedic Journal reviewed data from about 5,000 joint surgeries and determined that about one percent of patients died during a first-time joint surgery and about 3 percent during a revision joint surgery. Metallosis Osteonecrosi Device loosening Fracture Dislocation Death 7% In 2007, the Journal of Arthroplasty found that / % of patients implanted with ceramic devices like the Trident hip system developed squeaking in the device. In January 2008, Stryker voluntarily RECALLED the Trident hip system. In June, the FDA approved Stryker's Rejuvenate Modular hip device for sale on the market. From 2005 to 2007, a Large Number of Complaints were received by Stryker regarding its Trident device. In April 2012, Stryker issues an "Urgent Safety Alert" regarding side effects linked to its two hip replacement products. In July 2012, Stryker issues a voluntary recall for its Rejuvenate Modular and ABG II hip replacement systems. 000 In March 2007, the FDA issued a warning to Stryker after it discovered that the company's Ireland and New Jersey manufacturing plants Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 "Are NOT in Conformity with the Current Good Manufacturing Practice Requirements." for a free legal consultation. Stryker Hip Replacement In July 2012, Stryker Orthopaedics recalled two of its hip replacement products, the Rejuvenate Modular and the ABG II. This recall came just years after the FDA approved the Rejuvenate device in June 2008 device and the ABG II device in November 2009. Both of these products were designed using the dangerous metal-on-metal method. Previously in January 2008, Stryker had recalled its Trident hip system because its "CeramTec" material was not durable. Common Side Effects: Too Many 1% + 3% = Dead Swelling Pain Serious Side Effects: "Squeaky Joints" Osteolysis Ossification Infection Debris buildup The lowa Orthopaedic Journal reviewed data from about 5,000 joint surgeries and determined that about one percent of patients died during a first-time joint surgery and about 3 percent during a revision joint surgery. Metallosis Osteonecrosi Device loosening Fracture Dislocation Death 7% In 2007, the Journal of Arthroplasty found that / % of patients implanted with ceramic devices like the Trident hip system developed squeaking in the device. In January 2008, Stryker voluntarily RECALLED the Trident hip system. In June, the FDA approved Stryker's Rejuvenate Modular hip device for sale on the market. From 2005 to 2007, a Large Number of Complaints were received by Stryker regarding its Trident device. In April 2012, Stryker issues an "Urgent Safety Alert" regarding side effects linked to its two hip replacement products. In July 2012, Stryker issues a voluntary recall for its Rejuvenate Modular and ABG II hip replacement systems. 000 In March 2007, the FDA issued a warning to Stryker after it discovered that the company's Ireland and New Jersey manufacturing plants Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 "Are NOT in Conformity with the Current Good Manufacturing Practice Requirements." for a free legal consultation.